









Mercado
/
Acciones
/
nasdaq-neo
/

Neogenomics Inc

NEO

8.620USD

+0.510+6.29%

Cierre 09/18, 16:00（ET）Cotizaciones retrasadas 15 min

1.11BCap. mercado

PérdidaP/E TTM



Neogenomics Inc

8.620

+0.510+6.29%

Descripción general Compañía Finanzas Análisis

NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.

Información de la empresa

Símbolo de cotizaciónNEO

Nombre de la empresaNeogenomics Inc

Fecha de salida a bolsaDec 10, 2012

Director ejecutivoMr. Antony P. Zook

Número de empleados2200

Tipo de seguridadOrdinary Share

Fin del año fiscalDec 10

Dirección9490 Neogenomics Way

CiudadFORT MYERS

Bolsa de valoresNASDAQ Capital Market Consolidated

PaísUnited States of America

Código postal33912

Teléfono12397680600

Sitio Webhttps://neogenomics.com/

Símbolo de cotizaciónNEO

Fecha de salida a bolsaDec 10, 2012

Director ejecutivoMr. Antony P. Zook

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

186.66K

+12.00%

Mr. Warren Stone

President, Chief Operating Officer

108.28K

+19.26%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Felicia Williams

Independent Director

7.16K

Ms. Marjorie C. Green

Independent Director

Mr. David B. Perez

Independent Director

Ms. Alicia Olivo

Executive Vice President, General Counsel & Business Development

Mr. Michael A. Kelly

Lead Independent Director

Mr. Antony P. Zook

Chief Executive Officer, Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

186.66K

+12.00%

Mr. Warren Stone

President, Chief Operating Officer

108.28K

+19.26%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Felicia Williams

Independent Director

7.16K

Ms. Marjorie C. Green

Independent Director

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Clinical Services-Client direct billing

122.04M

72.63%

Clinical Services-Commercial Insurance

24.86M

14.79%

Clinical Services-Medicare and Medicaid

21.10M

12.56%

Clinical Services-Self-Pay

39.00K

0.02%

Sin datos

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Clinical Services-Client direct billing

122.04M

72.63%

Clinical Services-Commercial Insurance

24.86M

14.79%

Clinical Services-Medicare and Medicaid

21.10M

12.56%

Clinical Services-Self-Pay

39.00K

0.02%

Estadísticas de accionistas

Actualizado: vie., 15 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

13.76%

The Vanguard Group, Inc.

10.92%

Greenhouse Funds LLLP

5.75%

First Light Asset Management, LLC

5.30%

State Street Global Advisors (US)

3.96%

Otro

60.32%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

13.76%

The Vanguard Group, Inc.

10.92%

Greenhouse Funds LLLP

5.75%

First Light Asset Management, LLC

5.30%

State Street Global Advisors (US)

3.96%

Otro

60.32%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

50.14%

Investment Advisor/Hedge Fund

31.89%

Hedge Fund

14.04%

Research Firm

2.36%

Individual Investor

1.29%

Pension Fund

1.17%

Bank and Trust

0.61%

Sovereign Wealth Fund

0.09%

Family Office

0.05%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

571

126.82M

98.17%

-12.95M

2025Q1

596

131.44M

102.13%

-4.71M

2024Q4

585

127.59M

99.32%

-7.82M

2024Q3

589

129.38M

100.96%

-8.76M

2024Q2

597

131.21M

102.74%

-9.36M

2024Q1

633

132.83M

104.04%

-13.13M

2023Q4

672

130.90M

102.70%

-12.18M

2023Q3

691

124.98M

98.00%

-16.78M

2023Q2

691

121.76M

95.45%

-23.63M

2023Q1

704

120.14M

94.21%

-27.80M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

18.29M

14.21%

-356.84K

-1.91%

Mar 31, 2025

The Vanguard Group, Inc.

14.23M

11.06%

+17.23K

+0.12%

Mar 31, 2025

Greenhouse Funds LLLP

4.71M

3.66%

+6.43K

+0.14%

Mar 31, 2025

First Light Asset Management, LLC

6.04M

4.7%

+2.88M

+90.77%

Mar 31, 2025

State Street Global Advisors (US)

5.09M

3.95%

-109.12K

-2.10%

Mar 31, 2025

Macquarie Investment Management

4.68M

3.63%

+864.39K

+22.67%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

3.85M

2.99%

+408.27K

+11.88%

Mar 31, 2025

Schroder Investment Management North America Inc.

4.31M

3.35%

+509.99K

+13.42%

Mar 31, 2025

American Century Investment Management, Inc.

3.32M

2.58%

+426.34K

+14.74%

Mar 31, 2025

Millennium Management LLC

6.72M

5.22%

+5.29M

+371.20%

Mar 31, 2025

ETFs relacionados

Nombre

Proporción

Sin datos

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

